BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 22339763)

  • 1. Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence.
    Fernandes MC; Andrews NW
    FEMS Microbiol Rev; 2012 May; 36(3):734-47. PubMed ID: 22339763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Don't bother to knock--the cell invasion strategy of Trypanosoma cruzi.
    Tan H; Andrews NW
    Trends Parasitol; 2002 Oct; 18(10):427-8. PubMed ID: 12377585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding CD8
    Acosta Rodríguez EV; Araujo Furlan CL; Fiocca Vernengo F; Montes CL; Gruppi A
    Trends Parasitol; 2019 Nov; 35(11):899-917. PubMed ID: 31607632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Trypanosoma cruzi persistence in Chagas disease.
    Nagajyothi F; Machado FS; Burleigh BA; Jelicks LA; Scherer PE; Mukherjee S; Lisanti MP; Weiss LM; Garg NJ; Tanowitz HB
    Cell Microbiol; 2012 May; 14(5):634-43. PubMed ID: 22309180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.
    DosReis GA
    Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Evasion Strategies of Trypanosoma cruzi.
    Flávia Nardy A; Freire-de-Lima CG; Morrot A
    J Immunol Res; 2015; 2015():178947. PubMed ID: 26240832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.
    de Morais CG; Castro Lima AK; Terra R; dos Santos RF; Da-Silva SA; Dutra PM
    Biomed Res Int; 2015; 2015():324915. PubMed ID: 26090399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical immunology of human Chagas disease.
    Dutra WO; Rocha MO; Teixeira MM
    Trends Parasitol; 2005 Dec; 21(12):581-7. PubMed ID: 16236550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.
    Zhang L; Tarleton RL
    J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
    Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
    Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite-Mediated Remodeling of the Host Microfilament Cytoskeleton Enables Rapid Egress of Trypanosoma cruzi following Membrane Rupture.
    Ferreira ER; Bonfim-Melo A; Burleigh BA; Costales JA; Tyler KM; Mortara RA
    mBio; 2021 Jun; 12(3):e0098821. PubMed ID: 34154418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth.
    Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A
    Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease.
    Marinho CR; Bucci DZ; Dagli ML; Bastos KR; Grisotto MG; Sardinha LR; Baptista CR; Gonçalves CP; Lima MR; Alvarez JM
    Infect Immun; 2004 Apr; 72(4):2350-7. PubMed ID: 15039360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine responses in Trypanosoma cruzi-infected children in Paraguay.
    Samudio M; Montenegro-James S; Cabral M; Martinez J; Rojas de Arias A; James MA
    Am J Trop Med Hyg; 1998 Jan; 58(1):119-21. PubMed ID: 9452302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is It Possible to Intervene in the Capacity of
    Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
    Front Immunol; 2021; 12():789145. PubMed ID: 34975884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of apoptosis for immune regulation in Chagas disease.
    DosReis GA; Lopes MF
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():259-62. PubMed ID: 19753482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
    Pellegrini A; Guiñazu N; Giordanengo L; Cano RC; Gea S
    Future Microbiol; 2011 Dec; 6(12):1521-33. PubMed ID: 22122446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology.
    Gironès N; Carrasco-Marin E; Cuervo H; Guerrero NA; Sanoja C; John S; Flores-Herráez R; Fernández-Prieto L; Chico-Calero I; Salgado H; Carrión J; Fresno M
    Ann N Y Acad Sci; 2007 Jun; 1107():434-44. PubMed ID: 17804572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.